181 related articles for article (PubMed ID: 30547435)
1. Repurposing Drugs Based on Evolutionary Relationships Between Targets of Approved Drugs and Proteins of Interest.
Chakraborti S; Ramakrishnan G; Srinivasan N
Methods Mol Biol; 2019; 1903():45-59. PubMed ID: 30547435
[TBL] [Abstract][Full Text] [Related]
2. A Computational Bipartite Graph-Based Drug Repurposing Method.
Zheng S; Ma H; Wang J; Li J
Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
[TBL] [Abstract][Full Text] [Related]
3. Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv.
Ramakrishnan G; Chandra NR; Srinivasan N
Mol Biosyst; 2015 Dec; 11(12):3316-31. PubMed ID: 26429199
[TBL] [Abstract][Full Text] [Related]
4. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
6. Web-based drug repurposing tools: a survey.
Sam E; Athri P
Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
[TBL] [Abstract][Full Text] [Related]
7. Exploring anti-malarial potential of FDA approved drugs: an in silico approach.
Ramakrishnan G; Chandra N; Srinivasan N
Malar J; 2017 Jul; 16(1):290. PubMed ID: 28720135
[TBL] [Abstract][Full Text] [Related]
8. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
9. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
10. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.
Moosavinasab S; Patterson J; Strouse R; Rastegar-Mojarad M; Regan K; Payne PR; Huang Y; Lin SM
Database (Oxford); 2016; 2016():. PubMed ID: 27189611
[TBL] [Abstract][Full Text] [Related]
11. A Drug Repurposing Method Based on Drug-Drug Interaction Networks and Using Energy Model Layouts.
Udrescu M; Udrescu L
Methods Mol Biol; 2019; 1903():185-201. PubMed ID: 30547443
[TBL] [Abstract][Full Text] [Related]
12. In Silico Identification of Proteins Associated with Drug-induced Liver Injury Based on the Prediction of Drug-target Interactions.
Ivanov S; Semin M; Lagunin A; Filimonov D; Poroikov V
Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28145637
[TBL] [Abstract][Full Text] [Related]
13. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
Guney E
Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
[TBL] [Abstract][Full Text] [Related]
14. Homopharma: a new concept for exploring the molecular binding mechanisms and drug repurposing.
Chiu YY; Tseng JH; Liu KH; Lin CT; Hsu KC; Yang JM
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S8. PubMed ID: 25521038
[TBL] [Abstract][Full Text] [Related]
15. Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning.
Shameer K; Glicksberg BS; Hodos R; Johnson KW; Badgeley MA; Readhead B; Tomlinson MS; O'Connor T; Miotto R; Kidd BA; Chen R; Ma'ayan A; Dudley JT
Brief Bioinform; 2018 Jul; 19(4):656-678. PubMed ID: 28200013
[TBL] [Abstract][Full Text] [Related]
16. An Analytical Review of Computational Drug Repurposing.
Sadeghi SS; Keyvanpour MR
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing: a better approach for infectious disease drug discovery?
Law GL; Tisoncik-Go J; Korth MJ; Katze MG
Curr Opin Immunol; 2013 Oct; 25(5):588-92. PubMed ID: 24011665
[TBL] [Abstract][Full Text] [Related]
18. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
Wang R; Li S; Cheng L; Wong MH; Leung KS
BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
[TBL] [Abstract][Full Text] [Related]
19. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
20. Computational Drug Repurposing Based on a Recommendation System and Drug-Drug Functional Pathway Similarity.
Shao M; Jiang L; Meng Z; Xu J
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
